col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


80 Results       Page 1

 [1] 
Elsevier: Journal of Autoimmunity
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―21 mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses Jet van den Dijssel, Mariël C. Duurland, Veronique AL. Konijn, Laura YL. Kummer, Ruth R. Hagen, Lisan H. Kuijper, et al. (+73)
2 [GO] 2023―Nov―11 Novel and unique rheumatoid factors cross-react with viral epitopes in COVID-19 Maya F. Amjadi, Maxwell H. Parker, Ryan R. Adyniec, Zihao Zheng, Alex M. Robbins, S. Janna Bashar, et al. (+4)
3 [GO] 2023―Oct―10 Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients Christa Lichtensteiger, Maximilian Koblischke, Fiamma Berner, Ann-Kristin Jochum, Tobias Sinnberg, Beatrice Balciunaite, et al. (+22)
4 [GO] 2023―Jun―12 Molecular mimicry and autoimmunity in the time of COVID-19 Manuel Rojas, María Herrán, Carolina Ramírez-Santana, Patrick S.C. Leung, Juan Manuel-Anaya, William M. Ridgway, M. Eric Gershwin
5 [GO] 2023―Jun―12 Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study Renske G Kamperman, Ester Mm van Leeuwen, Myrthe Willems, Anneke J van der Kooi, Kyra A Gelderman, Dörte Hamann, et al. (+7)
6 [GO] 2023―May―15 Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines Chuang-Wei Wang, Chun-Bing Chen, Chun-Wei Lu, Wei-Ti Chen, Rosaline Chung-Yee Hui, Tsu-Man Chiu, et al. (+12)
7 [GO] 2023―Mar―02 Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases Raffaella Greco, John A. Snowden, Nina Simone Knelange, Gloria Tridello, Carlotta Cacciatore, Alienor Xhaard, et al. (+8)
8 [GO] 2023―Jan―09 Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non-to low-responders and B cell deficient rheumatic disease patients Alexander ten Hagen, Sandra Hermann, Elisa Habermann, Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Veronika Scholz, et al. (+7)
9 [GO] 2023―Jan―06 Pre-existing conditions associated with post-acute sequelae of COVID-19 Elizabeth T. Jacobs, Collin J. Catalfamo, Paulina M. Colombo, Sana M. Khan, Erika Austhof, Felina Cordova-Marks, et al. (+3)
10 [GO] 2023―Jan―02 Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations Koos P.J. van Dam, Luuk Wieske, Eileen W. Stalman, Laura Y.L. Kummer, Jesse Roosen, Zoé L.E. van Kempen, et al. (+52)
11 [GO] 2022―Dec―22 Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases Daniel Mrak, Felix Kartnig, Daniela Sieghart, Elisabeth Simader, Helga Radner, Peter Mandl, et al. (+12)
12 [GO] 2022―Dec―16 Comprehensive description of adult-onset Still's disease after COVID-19 vaccination Pascale Palassin, Virginie Bres, Samaher Hassan, Ange Alfonsi, Nathalie Massy, Valérie Gras-Champel, et al. (+2)
13 [GO] 2022―Nov―29 Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus national vaccine registry for ImmuNe diseases Singapore (CONVIN-SING) Margaret Ma, Amelia Santosa, Warren Fong, C.H.E.W. Li-Ching, Andrea Hl Low, Annie Law, et al. (+24)
14 [GO] 2022―Nov―11 On the peptide binding affinity changes in population-specific HLA repertoires to the SARS-CoV-2 variants Delta and Omicron Lu-Chun Chen, Stepan Nersisyan, Chang-Jiun Wu, Che-Mai Chang, Alexander Tonevitsky, Chin-Lin Guo, Wei-Chiao Chang
15 [GO] 2022―Oct―11 Induction of cross-reactive, mucosal anti-SARS-CoV-2 antibody responses in rheumatoid arthritis patients after 3rd dose of COVID-19 vaccination M. Bondareva, P. Letz, K. Karberg, E. Schrezenmeier, I. Semin, H. Rincon-Arevalo, et al. (+4)
16 [GO] 2022―Oct―04 Risk for uveitis relapse after COVID-19 vaccination Zhenyu Zhong, Qiuying Wu, Yuxian Lai, Lingyu Dai, Yu Gao, Weiting Liao, et al. (+2)
17 [GO] 2022―Sep―20 Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity? Hiroki Hosoi, Misato Tane, Hideki Kosako, Masaki Ibe, Masahiro Takeyama, Shogo Murata, et al. (+2)
18 [GO] 2022―Sep―12 Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases Yves Renaudineau, Laurent Sailler, Florence Abravanel, Jacques Izopet, Adrien Delourme, Damien Biotti, et al. (+5)
19 [GO] 2022―Sep―07 SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis Cumali Efe, Koray Taşçılar, Alessio Gerussi, Francesca Bolis, Craig Lammert, Berat Ebik, et al. (+39)
20 [GO] 2022―Aug―24 Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review Yhojan Rodríguez, Manuel Rojas, Santiago Beltrán, Fernando Polo, Laura Camacho-Domínguez, Samuel David Morales, et al. (+2)
21 [GO] 2022―Aug―22 IgA-diseases associated to SARS-CoV-2 infection or vaccination: A systematic literature review Gabriel Bronz, Pietro B. Faré, Sebastiano A.G. Lava, Mario G. Bianchetti, Giacomo D. Simonetti, Martin Scoglio, et al. (+3)
22 [GO] 2022―Aug―18 COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman Wangbin Ning, Wanli Xu, Xiaomei Cong, Hongkuan Fan, Gary Gilkeson, Xueling Wu, et al. (+2)
23 [GO] 2022―Aug―05 Autoimmune hepatitis following COVID-19 vaccination Arantzazu Izagirre, Teresa Arzallus, Maddi Garmendia, Silvia Torrente, Agustin Castiella, Eva María Zapata
24 [GO] 2022―Jul―20 COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study Matheus Vieira, Cloé Comarmond, Julien Labreuche, Adrien Mirouse, David Saadoun, Christophe Richez, et al. (+4)
25 [GO] 2022―Jul―11 Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases Clodoveo Ferri, Laura Gragnani, Vincenzo Raimondo, Marcella Visentini, Dilia Giuggioli, Serena Lorini, et al. (+39)
26 [GO] 2022―Jun―13 Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy Davide Firinu, Giuseppe Fenu, Giuseppina Sanna, Giulia A. Costanzo, Andrea Perra, Marcello Campagna, et al. (+10)
27 [GO] 2022―Jun―09 COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases Athanasios-Dimitrios Bakasis, Clio P. Mavragani, Paraskevi V. Voulgari, Nafsika Gerolymatou, Ourania D. Argyropoulou, Panayiotis G. Vlachoyiannopoulos, et al. (+3)
28 [GO] 2022―Apr―14 Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong Xue Li, Le Gao, Xinning Tong, Vivien K.Y. Chan, Celine S.L. Chui, Francisco T.T. Lai, et al. (+6)
29 [GO] 2022―Apr―11 High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients Martina Fabris, Ginevra De Marchi, Rossana Domenis, Federica Caponnetto, Silvia Guella, Chiara Dal Secco, et al. (+5)
30 [GO] 2022―Feb―24 Relapsed and newly diagnosed Graves’ disease due to immunization against COVID-19: A case series and review of the literature Hayri Bostan, Bekir Ucan, Muhammed Kizilgul, Murat Calapkulu, Sema Hepsen, Umran Gul, et al. (+2)
31 [GO] 2022―Jan―01 Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy Azizul Haque, Anudeep B. Pant
32 [GO] 2021―Dec―28 Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination G. Fiorillo, S. Pancetti, A. Cortese, F. Toso, S. Manara, A. Costanzo, R.G. Borroni
33 [GO] 2021―Dec―14 Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence? Shotaro Tabata, Hiroki Hosoi, Shogo Murata, Satomi Takeda, Toshiki Mushino, Takashi Sonoki
34 [GO] 2021―Dec―13 Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies Saathvik R. Kannan, Austin N. Spratt, Kalicharan Sharma, Hitendra S. Chand, Siddappa N. Byrareddy, Kamal Singh
35 [GO] 2021―Dec―06 Ferritin - from iron, through inflammation and autoimmunity, to COVID-19 Naim Mahroum, Amal Alghory, Zeynep Kiyak, Abdulkarim Alwani, Ravend Seida, Mahmoud Alrais, Yehuda Shoenfeld
36 [GO] 2021―Nov―11 Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up? Enver Avci, Fatma Abasiyanik
37 [GO] 2021―Nov―10 Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups Clodoveo Ferri, Francesco Ursini, Laura Gragnani, Vincenzo Raimondo, Dilia Giuggioli, Rosario Foti, et al. (+42)
38 [GO] 2021―Oct―28 A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases Athanasios G. Tzioufas, Athanasios-Dimitrios Bakasis, Andreas V. Goules, Kleopatra Bitzogli, Ilir I. Cinoku, Loukas G. Chatzis, et al. (+18)
39 [GO] 2021―Oct―28 Post COVID-19 hospitalizations in patients with chronic inflammatory diseases - A nationwide cohort study Bente Mertz Nørgård, Floor Dijkstra Zegers, Jan Nielsen, Jens Kjeldsen
40 [GO] 2021―Oct―27 Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence Isabel Garrido, Susana Lopes, Manuel Sobrinho Simões, Rodrigo Liberal, Joanne Lopes, Fátima Carneiro, Guilherme Macedo
41 [GO] 2021―Oct―26 Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data Luigi Cari, Mahdieh Naghavi Alhosseini, Paolo Fiore, Sabata Pierno, Sabrina Pacor, Alberta Bergamo, et al. (+2)
42 [GO] 2021―Oct―13 A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination Armando Patrizio, Silvia Martina Ferrari, Alessandro Antonelli, Poupak Fallahi
43 [GO] 2021―Oct―12 Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network Rahul Raiker, Haig Pakhchanian, Charles DeYoung, Latika Gupta, Sinan Kardeş, Sakir Ahmed, Chengappa Kavadichanda
44 [GO] 2021―Sep―27 Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination Massimo Cugno, Paolo Macor, Mara Giordano, Marcello Manfredi, Samantha Griffini, Elena Grovetti, et al. (+9)
45 [GO] 2021―Aug―11 Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses Saathvik R. Kannan, Austin N. Spratt, Alisha R. Cohen, S. Hasan Naqvi, Hitendra S. Chand, Thomas P. Quinn, et al. (+3)
46 [GO] 2021―Jul―28 Autoimmune hepatitis triggered by SARS-CoV-2 vaccination Élise Vuille-Lessard, Matteo Montani, Jaume Bosch, Nasser Semmo
47 [GO] 2021―Jul―27 Thrombocytopenia after COVID-19 vaccination Kristian Kragholm, Maurizio Sessa, Thomas Mulvad, Mikkel Porsborg Andersen, Helle Collatz-Christensen, Stig Nikolaj Blomberg, et al. (+8)
48 [GO] 2021―Jul―20 Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study Mar Masiá, Marta Fernández-González, Guillermo Telenti, Vanesa Agulló, José A. García, Sergio Padilla, et al. (+4)
49 [GO] 2021―Jul―16 COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review Athanasios-Dimitrios Bakasis, Clio P. Mavragani, Kyriaki A. Boki, Athanasios G. Tzioufas, Panayiotis G. Vlachoyiannopoulos, Ioanna E. Stergiou, et al. (+2)
50 [GO] 2021―Jul―15 Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity? Michele Ghielmetti, Helen Dorothea Schaufelberger, Giorgina Mieli-Vergani, Andreas Cerny, Eric Dayer, Diego Vergani, Benedetta Terziroli Beretta-Piccoli
51 [GO] 2021―Jun―23 Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data Luigi Cari, Paolo Fiore, Mahdieh Naghavi Alhosseini, Gianni Sava, Giuseppe Nocentini
52 [GO] 2021―Jun―21 Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals Holger Lingel, Stefan Meltendorf, Ulrike Billing, Christoph Thurm, Katrin Vogel, Christiane Majer, et al. (+7)
53 [GO] 2021―Jun―15 Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines Jimin Hwang, Se Bee Lee, Seung Won Lee, Min Ho Lee, Ai Koyanagi, Louis Jacob, et al. (+4)
54 [GO] 2021―Jun―11 Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19 Ana I. Rodriguez-Perez, Carmen M. Labandeira, Maria A. Pedrosa, Rita Valenzuela, Juan A. Suarez-Quintanilla, María Cortes-Ayaso, et al. (+2)
55 [GO] 2021―May―19 Differences in venous immunothrombosis in severe COVID-19 pneumonia and Vaccine-Induced Thrombotic Thrombocytopenia (VITT) - It's in the viral DNA Dennis McGonagle, Gabriele De Marco, Charles Bridgewood
56 [GO] 2021―May―01 A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine Haralampos M. Moutsopoulos
57 [GO] 2021―Apr―30 Corrigendum to “Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19” [J. Autoimmun. 117C (2020) 102595] Luca Valenti, Samantha Griffini, Giuseppe Lamorte, Elena Grovetti, Sara Colonia Uceda Renteria, Francesco Malvestiti, et al. (+6)
58 [GO] 2021―Apr―27 An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19 Julia Y. Wang, Wei Zhang, Michael W. Roehrl, Victor B. Roehrl, Michael H. Roehrl
59 [GO] 2021―Mar―26 Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark Jens Kjeldsen, Jan Nielsen, Torkell Ellingsen, Torben Knudsen, Rasmus Gaardskær Nielsen, Michael Due Larsen, et al. (+2)
60 [GO] 2021―Feb―15 Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies - A Danish population-based cohort study Mohamed Attauabi, Jakob Benedict Seidelin, Oluf Krautwald Felding, Mads Damsgaard Wewer, Laura Kirstine Vinther Arp, Melek Zahra Sarikaya, et al. (+4)
61 [GO] 2021―Jan―22 COVID-19 convalescent plasma composition and immunological effects in severe patients Yeny Acosta-Ampudia, Diana M. Monsalve, Manuel Rojas, Yhojan Rodríguez, Juan Esteban Gallo, Juan Carlos Salazar-Uribe, et al. (+9)
62 [GO] 2021―Jan―15 Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status Yonggang Zhou, Jinhe Zhang, Dongyao Wang, Dong Wang, Wuxiang Guan, Jingkun Qin, et al. (+11)
63 [GO] 2021―Jan―12 Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19 Luca Valenti, Samantha Griffini, Giuseppe Lamorte, Elena Grovetti, Sara Colonia Uceda Renteria, Francesco Malvestiti, et al. (+6)
64 [GO] 2020―Dec―16 The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature Lucia Novelli, Francesca Motta, Maria De Santis, Aftab A. Ansari, M. Eric Gershwin, Carlo Selmi
65 [GO] 2020―Nov―30 A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center Juan C. Sarmiento-Monroy, Gerard Espinosa, Maria-Carlota Londoño, Fernanda Meira, Berta Caballol, Sara Llufriu, et al. (+28)
66 [GO] 2020―Oct―30 Complement activation and endothelial perturbation parallel COVID-19 severity and activity Massimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, Samantha Griffini, Elena Grovetti, Adriana Torri, et al. (+17)
67 [GO] 2020―Aug―20 High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients Enrique Iglesias Julián, María López Veloso, Noelia de la Torre Ferrera, Julio Cesar Barraza Vengoechea, Pedro David Delgado-López, María Colazo Burlato, et al. (+9)
68 [GO] 2020―Jul―16 Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study Oscar Moreno-Pérez, Mariano Andres, Jose-Manuel Leon-Ramirez, José Sánchez-Payá, Juan Carlos Rodríguez, Rosario Sánchez, et al. (+4)
69 [GO] 2020―Jul―08 Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients Lorenzo M. Canziani, Serena Trovati, Enrico Brunetta, Amidio Testa, Maria De Santis, Emilio Bombardieri, et al. (+17)
70 [GO] 2020―Jul―03 Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab Austin R. Morrison, Joseph M. Johnson, Kristin M. Griebe, Mathew C. Jones, John J. Stine, Laura N. Hencken, et al. (+7)
71 [GO] 2020―Jun―16 Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 Yhojan Rodríguez, Lucia Novelli, Manuel Rojas, Maria De Santis, Yeny Acosta-Ampudia, Diana M. Monsalve, et al. (+7)
72 [GO] 2020―Jun―08 SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients M. Zen, E. Fuzzi, D. Astorri, F. Saccon, R. Padoan, L. Ienna, et al. (+17)
73 [GO] 2020―May―16 Corrigendum to “The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China” [J. Autoimmun. 109C (2020) 102434] Yongshi Yang, Fujun Peng, Runsheng Wang, Ming Yang, Kai Guan, Taijiao Jiang, et al. (+3)
74 [GO] 2020―Apr―24 Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience Ying Sun, Yanli Dong, Lifeng Wang, Huan Xie, Baosen Li, Christopher Chang, Fu-sheng Wang
75 [GO] 2020―Apr―17 The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 Carlo Perricone, Paola Triggianese, Elena Bartoloni, Giacomo Cafaro, Angelo F. Bonifacio, Roberto Bursi, et al. (+2)
76 [GO] 2020―Apr―13 Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19 Guoping Li, Xiang He, Lei Zhang, Qin Ran, Junyi Wang, Anying Xiong, et al. (+4)
77 [GO] 2020―Apr―10 Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? Bingwen Liu, Min Li, Zhiguang Zhou, Xuan Guan, Yufei Xiang
78 [GO] 2020―Apr―02 Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy Angela Ceribelli, Francesca Motta, Maria De Santis, Aftab A. Ansari, William M. Ridgway, M. Eric Gershwin, Carlo Selmi
79 [GO] 2020―Mar―03 The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China Yongshi Yang, Fujun Peng, Runsheng Wang, Kai Guan, Taijiao Jiang, Guogang Xu, et al. (+2)
80 [GO] 2020―Feb―26 The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak Hussin A. Rothan, Siddappa N. Byrareddy
 [1] 

80 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec